New patent expiration for Mylan Institutional drug ULTIVA

Annual Drug Patent Expirations for ULTIVA Ultiva is a drug marketed by Mylan Institutional and is included in one NDA. It is available from one supplier. There is one patent…

The post New patent expiration for Mylan Institutional drug ULTIVA appeared first on DrugPatentWatch.


Comments are closed.

Biotechblog